Stocks · Healthcare · Biotechnology
Seer, Inc. SEER
$2.25 +2.27% Close, Oct 2, 2026 · NASDAQ · Market cap $123.7M
Expensive vs sector
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -511.4% from -558.1% a year earlier.
- Revenue over the last four quarters was $13.8M, down 13.3% from a year earlier, slowing from -2.8% a quarter earlier.
- The diluted share count fell 5.0% in a year, mainly through buybacks.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 18%
- Revenue growth, 3-year CAGRBottom 33%
- Revenue growth accelerationBottom 17%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 43%
- Gross marginBottom 30%
- Operating marginBottom 17%
- Accruals (lower is better)Top 37%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 14%
- Free-cash-flow yieldBottom 13%
- EBITDA / enterprise valueBottom 11%
- Sales / enterprise valueBottom 35%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 30%
- 6-month returnTop 30%
- 1-year return vs S&P 500Bottom 44%
- Distance from 52-week highTop 9%
- Trend checklist (0–4)Top 7%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 39%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 2%
- Upside to consensus price targetTop 44%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 22%
- Maximum drawdown, 3 yearsTop 10%
- Beta vs S&P 500 (lower is better)Bottom 35%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -2.8% | -13.3% | ↓ |
| Gross margin | 38.9% | 46.3% | ↑ |
| Operating margin | -558.1% | -511.4% | ↑ |
| FCF margin | -341.5% | -319.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -13.3% | -2.8% | ↓ | Bottom 18% |
| Gross margin | 46.3% | 38.9% | ↑ | Bottom 30% |
| Operating margin | -511.4% | -558.1% | ↑ | Bottom 17% |
| Net margin | -490.7% | -516.3% | ↑ | — |
| Free-cash-flow margin | -319.4% | -341.5% | ↑ | — |
| Return on invested capital | -28.5% | — | Bottom 43% | |
| Revenue growth, 3-year CAGR | 3.2% | — | Bottom 33% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.6%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 76.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -26.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 3.79%
- Shareholder yield
- 3.79%
- Share count change, 1 year
- -5.0%
- Share count change, 3-year CAGR
- -4.7%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 11, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -1.8%
- Average 2-day reaction, last 8
- -0.8%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $4.00
- Target vs current price
- +77.8%
- Analysts with a rating
- 4
- Share rating Buy or Strong Buy
- 25%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 11, 2026 | -14.8% | +0.0% | -6.0% | -9.7% | — |
| May 13, 2026 | -1.7% | -2.7% | -7.7% | -7.1% | +19.2% |
| Feb 26, 2026 | +9.4% | -0.5% | -11.5% | -17.2% | -15.3% |
| Nov 6, 2025 | +0.0% | -0.5% | -4.1% | -11.5% | -17.5% |
| Aug 6, 2025 | +15.4% | -2.8% | +3.8% | -4.7% | +4.7% |
| May 13, 2025 | +8.1% | +1.6% | +9.5% | +18.0% | +6.3% |
| Feb 27, 2025 | -9.7% | -3.5% | -10.5% | -20.2% | -8.8% |
| Nov 6, 2024 | -17.2% | +2.0% | +11.3% | +21.7% | +12.3% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.31 | -$0.27 | -14.8% | $3.1M |
| May 13, 2026 | -$0.30 | -$0.30 | -1.7% | $2.8M |
| Feb 26, 2026 | -$0.29 | -$0.32 | +9.4% | $4.2M |
| Nov 6, 2025 | -$0.32 | -$0.32 | +0.0% | $4.1M |
| Aug 6, 2025 | -$0.33 | -$0.39 | +15.4% | $4.1M |
| May 13, 2025 | -$0.34 | -$0.37 | +8.1% | $4.2M |
| Feb 27, 2025 | -$0.34 | -$0.31 | -9.7% | $3.9M |
| Nov 6, 2024 | -$0.34 | -$0.29 | -17.2% | $3.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 8.67× | — | — | Bottom 35% |
| Free-cash-flow yield | -35.76% | — | — | Bottom 13% |
| Earnings yield | -54.22% | — | — | Bottom 14% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✓ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 5
- Days above the 200-day average
- 6
- 50-day average slope (20 days)
- -0.6%
- 200-day average slope (20 days)
- +0.4%
- Distance from 50-day average
- +10.8%
- Distance from 200-day average
- +18.4%
- RSI (14)
- 71.3
- Relative volume
- 0.71×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 39.9%
- Volatility vs own 5-year history
- 12th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.41
- Correlation with S&P 500
- 0.40
- Current drawdown from 1-year high
- -5.1%
- Maximum drawdown, 3 years
- -36.5%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jan 20, 2021 | Nov 16, 2023 | -98.3% | 712 days | Not yet recovered |
| Dec 10, 2020 | Jan 4, 2021 | -33.4% | 15 days | 10 days (Jan 19, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $123.7M
- EPS, diluted (TTM)
- -$1.22
- Revenue (TTM)
- $13.8M
- 52-week range
- $1.55 – $2.41
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $6.4M | $14.7M | $15.2M | $13.9M | $16.1M |
| Gross profit | -$374,000 | $384,000 | $1.4M | $6.8M | $8.0M |
| Operating income | -$71.7M | -$98.0M | -$104.9M | -$100.1M | -$78.0M |
| Net income | -$71.2M | -$93.0M | -$86.3M | -$86.6M | -$73.6M |
| EPS (diluted) | -$1.13 | -$1.42 | -$1.35 | -$1.39 | -$1.28 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.9M | $3.9M | $4.1M | $3.9M | $4.0M | $4.1M | $2.7M | $3.1M |
| Net income | -$21.3M | -$21.7M | -$19.9M | -$19.4M | -$18.2M | -$16.0M | -$16.8M | -$16.9M |
| EPS (diluted) | -$0.35 | -$0.35 | -$0.34 | -$0.33 | -$0.32 | -$0.29 | -$0.30 | -$0.31 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$46.3M | -$60.8M | -$59.1M | -$46.1M | -$44.4M |
| Capital expenditure | -$6.9M | -$10.3M | -$7.3M | -$3.6M | -$1.8M |
| Free cash flow | -$53.3M | -$71.0M | -$66.4M | -$49.7M | -$46.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $102.9M | -$20,000 | -$13,000 | -$11.8M | -$9.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $152.9M
- Total assets
- $256.6M
- Total liabilities
- $31.0M
- Total debt
- $22.4M
- Net debt
- -$3.7M
- Shareholders’ equity
- $225.7M
As of Jun 30, 2026 (filed Aug 11, 2026).
Short interest
- Shares sold short
- 87,329
- Days to cover
- 1.00
- Change vs previous report
- -40.1%
FINRA short interest, settlement date Sep 15, 2026.